RAD51D protects against MLH1-dependent cytotoxic responses to O6-methylguanine

DNA Repair

Volumn 9, Issue 4, 2010, Pages 458-467

  Rajesh, Preeti ^a   Rajesh, Changanamkandath ^a   Wyatt, Michael D ^a   Pittman, Douglas L ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alkylating agents; Homologous recombination; Mismatch repair; MLH1; RAD51D

Indexed keywords

6 O METHYLGUANINE; HISTONE H2AX; METHYLNITRONITROSOGUANIDINE; PROTEIN MLH1; PROTEIN P53; RAD51 PROTEIN; RAD51D PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE INTERACTION; GENETIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; KNOCKOUT MOUSE; MISMATCH REPAIR; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEFICIENCY; SENSITIZATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; FIBROBLASTS; G2 PHASE; GUANINE; METHYLNITRONITROSOGUANIDINE; MICE; NUCLEAR PROTEINS; RAD51 RECOMBINASE;

MAMMALIA;

EID: 77949655109     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2010.01.009     Document Type: Article

References (39)

1. Margison G.P., Santibanez Koref M.F., and Povey A.C. Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis 17 (2002) 483-487
2. Sedgwick B. Repairing DNA-methylation damage. Nat. Rev. Mol. Cell Biol. 5 (2004) 148-157
3. Wyatt M.D., and Pittman D.L. Methylating agents and DNA repair responses: methylated bases and sources of strand breaks. Chem. Res. Toxicol. 19 (2006) 1580-1594
4. Kaina B., Christmann M., Naumann S., and Roos W.P. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 6 (2007) 1079-1099
5. Gerson S.L. MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer 4 (2004) 296-307
6. Cejka P., and Jiricny J. Interplay of DNA repair pathways controls methylation damage toxicity in Saccharomyces cerevisiae. Genetics 179 (2008) 1835-1844
7. Bignami M., O'Driscoll M., Aquilina G., and Karran P. Unmasking a killer: DNA O6-methylguanine and the cytotoxicity of methylating agents. Mutat. Res./Rev. Mutat. Res. 462 (2000) 71-82
8. Karran P., and Marinus M.G. Mismatch correction at O6-methylguanine residues in E. coli DNA. Nature 296 (1982) 868-869
9. Yoshioka K., Yoshioka Y., and Hsieh P. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol. Cell 22 (2006) 501-510
10. Stojic L., Mojas N., Cejka P., Di Pietro M., Ferrari S., Marra G., and Jiricny J. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 18 (2004) 1331-1344
11. Schroering A.G., and Williams K.J. Rapid induction of chromatin-associated DNA mismatch repair proteins after MNNG treatment. DNA Repair (Amst) 7 (2008) 951-969
12. D'Atri S., Tentori L., Lacal P.M., Graziani G., Pagani E., Benincasa E., Zambruno G., Bonmassar E., and Jiricny J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol. 54 (1998) 334-341
13. Zhang H., Richards B., Wilson T., Lloyd M., Cranston A., Thorburn A., Fishel R., and Meuth M. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res. 59 (1999) 3021-3027
14. Hickman M.J., and Samson L.D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10764-10769
15. Roos W.P., Batista L.F., Naumann S.C., Wick W., Weller M., Menck C.F., and Kaina B. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 26 (2007) 186-197
16. Roos W.P., Nikolova T., Quiros S., Naumann S.C., Kiedron O., Zdzienicka M.Z., and Kaina B. Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair (Amst) 8 (2009) 72-86
17. Tsaryk R., Fabian K., Thacker J., and Kaina B. Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide. Cancer Lett. 239 (2006) 305-313
18. Mojas N., Lopes M., and Jiricny J. Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev. 21 (2007) 3342-3355
19. Armstrong M.J., and Galloway S.M. Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. Mutat. Res. 373 (1997) 167-178
20. Galloway S.M., Greenwood S.K., Hill R.B., Bradt C.I., and Bean C.L. A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. Mutat. Res. 346 (1995) 231-245
21. Kaina B., Fritz G., and Coquerelle T. Contribution of O6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: new insights gained from studies of genetically engineered mammalian cell lines. Environ. Mol. Mutagen. 22 (1993) 283-292
22. Zhang H., Tsujimura T., Bhattacharyya N.P., Maher V.M., and McCormick J.J. O6-methylguanine induces intrachromosomal homologous recombination in human cells. Carcinogenesis 17 (1996) 2229-2235
23. Zhang H., Marra G., Jiricny J., Maher V.M., and McCormick J.J. Mismatch repair is required for O(6)-methylguanine-induced homologous recombination in human fibroblasts. Carcinogenesis 21 (2000) 1639-1646
24. Pittman D.L., and Schimenti J.C. Midgestation lethality in mice deficient for the RecA-related gene, Rad51d/Rad51l3. Genesis 26 (2000) 167-173
25. Smiraldo P.G., Gruver A.M., Osborn J.C., and Pittman D.L. Extensive chromosomal instability in Rad51d-deficient mouse cells. Cancer Res. 65 (2005) 2089-2096
26. Baker S.M., Plug A.W., Prolla T.A., Bronner C.E., Harris A.C., Yao X., Christie D.M., Monell C., Arnheim N., Bradley A., Ashley T., and Liskay R.M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13 (1996) 336-342
27. Tate E.H., Wilder M.E., Cram L.S., and Wharton W. A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solution. Cytometry 4 (1983) 211-215
28. Cejka P., Mojas N., Gillet L., Schar P., and Jiricny J. Homologous recombination rescues mismatch-repair-dependent cytotoxicity of SN1-type methylating agents in S. cerevisiae. Curr. Biol. 15 (2005) 1395-1400
29. Nowosielska A., Smith S.A., Engelward B.P., and Marinus M.G. Homologous recombination prevents methylation-induced toxicity in Escherichia coli. Nucl. Acids Res. 34 (2006) 2258-2268
30. Blough M.D., Zlatescu M.C., and Cairncross J.G. O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells. Cancer Res. 67 (2007) 580-584
31. Grombacher T., Eichhorn U., and Kaina B. p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene 17 (1998) 845-851
32. Lai J.C., Cheng Y.W., Goan Y.G., Chang J.T., Wu T.C., Chen C.Y., and Lee H. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. DNA Repair (Amst) 7 (2008) 1352-1363
33. Shiloh Y., and Becker Y. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents. Cancer Res. 41 (1981) 5114-5120
34. Wyatt M.D., Allan J.M., Lau A.Y., Ellenberger T.E., and Samson L.D. 3-Methyladenine DNA glycosylases: structure, function, and biological importance. Bioessays 21 (1999) 668-676
35. Paik J., Duncan T., Lindahl T., and Sedgwick B. Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase. Cancer Res. 65 (2005) 10472-10477
36. Rinne M.L., He Y., Pachkowski B.F., Nakamura J., and Kelley M.R. N-methylpurine DNA glycosylase overexpression increases alkylation sensitivity by rapidly removing non-toxic 7-methylguanine adducts. Nucleic Acids Res. 33 (2005) 2859-2867
37. Sobol R.W., Kartalou M., Almeida K.H., Joyce D.F., Engelward B.P., Horton J.K., Prasad R., Samson L.D., and Wilson S.H. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. J. Biol. Chem. 278 (2003) 39951-39959
38. Trivedi R.N., Wang X.H., Jelezcova E., Goellner E.M., Tang J.B., and Sobol R.W. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. Mol. Pharmacol. 74 (2008) 505-516
39. Klapacz J., Meira L.B., Luchetti D.G., Calvo J.A., Bronson R.T., Edelmann W., and Samson L.D. O6-methylguanine-induced cell death involves exonuclease 1 as well as DNA mismatch recognition in vivo. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 576-581